Legislative Changes and Decriminalization of Cannabis Consumption to Aid Market Growth

The medical cannabis market is set to witness noteworthy growth in the coming years, particularly in North America and Europe. The adoption of medical cannabis is set to scale new heights predominantly driven by legislative amendments that have played an important role in the decriminalization of cannabis consumption. In addition, these legislative changes have also led to a significant rise in cannabis production for therapeutic and medical purposes. The rise in demand for medical cannabis is largely backed by research activities and scientific advancements that offer valuable insights related to the potential benefits of medical cannabis to treat an array of diseases.

The growth of the medical cannabis market is likely to be primarily driven by a combination of political, social, and economic interests during the forecast period. At present, around 30 nations have legalized the therapeutic application of medical cannabis and cannabis extracts and as per the current trends, the number is set to grow over the assessment period– a factor that is set to boost the growth of the market for medical cannabis during the forecast period. The projected growth in the number of countries that are expected to decriminalize cannabis for medical purposes and rise in the number of research activities pertaining to the potential benefits of medical cannabis are some of the leading factors that are expected to drive the growth of the global medical cannabis market, which is projected to reach a value of US$ 52.8 Bn by the end of 2027.

medical cannabis market infographic

To know the scope of our report Get a Sample on Medical Cannabis Market 

Clinical Research and Evolving Legal Framework Globally to Boost Market Growth

Over the past decade, clinical research activities coupled with the evolving legal framework in various nations of Europe and North America have laid the foundation for the growth of the medical cannabis market. Research activities have played a key role in improving awareness regarding the link between cannabinoids and human physiology. Moreover, while the medical cannabis is projected to attract significant investments during the assessment period, it is likely to open up significant job opportunities in the STEM space. In recent times, research and development activities are increasingly focusing on investigating the physiology and biology of cannabinoids and an array of other bioactive compounds extracted from cannabis.

Get a glimpse of the in-depth analysis through our Report Brochure

Although the medical cannabis market is at a nascent stage, clinical research activities are anticipated to gain notable momentum in the upcoming years. In addition, as per the analysts at Transparency Market Research, collaborations between botanists, biologists, organic chemists, medical doctors, pharmacologists, along with experts in therapeutic product design, drug formulation, and clinical trial space will play a key role in the development of the medical cannabis market during the assessment period. Some of the most post promising benefits of medical cannabis include minimizing pain, nausea, and easing the different symptoms of the Parkinson’s disease. Furthermore, a considerable amount of research is being carried out to evaluate the potential of benefits and applications of medical cannabis to treat a myriad of skin conditions and mental health issues, including anxiety and PTSD.

North America and Europe to Provide Lucrative Opportunities to Medical Cannabis Market

Consumption of medical cannabis is set to witness unprecedented growth in the U.S., Canada, and several nations across the European Union. As per the current trends, medical cannabis is on the course of becoming one of the most prominent new consumer segments in the U.S. Some of the major factors that are likely to augment the consumption of medical cannabis is the shift in tide among consumers toward plant-based therapies, growing preference for natural alternatives over prescription drugs, and significant development in the wellness as a lifestyle space.

Governments May Legalize Use of Medical Cannabis amidst Economic Slowdown Due to COVID-19 Pandemic 

Due to the onset of the COVID-19 pandemic, analysts at the International Monetary Fund and the United Nations have projected that a global recession is on the cards. However, amidst the economic crisis, government authorities around the world could legalize the use of medical cannabis to create recession-proof jobs. While legalizing the use of medical cannabis is largely possible, research and development activities are expected to grow in the coming months aiming to unlock the complete potential of medical cannabis to treat different diseases. The consumption patterns of medical cannabis is expected to show a slight decline during the second quarter of 2020; consumption of medical cannabis particularly for medical applications is expected to grow. One of the major challenges that would require significant attention in the medical cannabis market would be streamlining the supply lines.

medical cannabis market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global medical cannabis market is set to grow at a staggering CAGR of 26.6% during the forecast period. The market growth can be primarily attributed to a host of factors, including legislative changes across different countries wherein decriminalization of cannabis and products derived from cannabis has played an important role. In addition, as governments across North America and Europe continue to regulate the production of medical cannabis, the demand for the same is expected to grow at a rapid pace. Research and development activities are anticipated to open up new applications of medical cannabis to treat a host of medical diseases in the coming years.  

Medical Cannabis Market: Overview

  • According to the latest report published by Transparency Market Research on the global medical cannabis market for the historical period 2017–2018 and forecast period from 2019 to 2027, higher demand for pain management products is projected to be a major driver of the global medical cannabis market during the forecast period
  • The global medical cannabis market was valued at US$ 8 Bn in 2018 and is anticipated to expand at a CAGR of 26.6% from 2019 to 2027
  • The report analyzes the current and future scenario of the global medical cannabis market
  • The global medical cannabis market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global medical cannabis market with respect to the segments based on derivatives, applications, route of administration, distribution channel, and region.
  • A detailed qualitative analysis of drivers, restraints, and opportunities of the global medical cannabis market has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the global medical cannabis market.
  • This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global medical cannabis market

Medical Cannabis Market: Key Drivers

  • Companies focus on capitalizing on medical cannabis products
    • The medicinal cannabis industry is expanding due to increase in cannabidiol (CBD) usage in various medical applications. Rise in the utilization of cannabidiol is due to increased legalization of medicinal cannabis and societal acceptance. Moreover, the FDA approval for CBD hemp oil for the treatment of epilepsy has fuelled its usage in the pharmaceutical industry. Hence, companies continue to improve the medicated solutions through enhanced CBD-based medication.
    • SanSal Wellness, committed to the research & development of improved hemp genetics cultivation and innovation, provides the global community with uncompromised quality hemp products, containing the highest quality, quantity, and consistency in the industry
  • Rise in incidence of joint & muscle pain
    • Musculoskeletal conditions are common causes of severe long-term pain and physical disability. Prevalence and incidence of musculoskeletal conditions increases with age. For instance, a report published in Osteoarthritis Cartilage journal stated that nearly 27 million adults in the U.S. and 8.5 million adults in the U.K. are estimated to have osteoarthritis (OA).
    • However, approaches in new research on arthritis and other bone inflammation disorders has opened a wide spectrum of knowledge on biologic medication
    • A study published in the Journal Pain (2017) indicated that medical cannabis could be a safe and useful treatment for osteoarthritis (OA) joint pain
    • In 2008, the Therapeutics and Clinical Risk Management Journal also indicated that Sativex, a cannabis derived oromucosal spray containing equal proportions of THC and cannabidiol, was approved in Canada for the treatment of central neuropathic pain in multiple sclerosis in 2005 and for intractable cancer pain in 2007

Medical Cannabis Market: Key Segments

  • In terms of derivative, the global medical cannabis market has been classified into cannabidiol (CBD), tetrahydrocannabinol (THC), and others
  • Based on application, the global medical cannabis market has been categorized into mental health management, neurological disorders management, and pain management
    • The mental health management segment has been segregated into anxiety, depression, and others (attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), etc.)
    • The neurological disorders management segment has been split into epilepsy, Alzheimer’s disease, Parkinson’s disease, and others (Huntington’s disease, multiple sclerosis, etc.)
    • The pain management segment has been divided into neuropathic pain, cancer pain, and others (post-operative, chronic pain, etc.)
  • In terms of route of administration, the global medical cannabis market has been classified into nasal, oral, and others (soft gels, cannabis oil, etc.)
  • Based on distribution channel, the global medical cannabis market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies
  • The market size and forecast for each of the segments have been provided in terms of US$ Mn from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year

Medical Cannabis Market: Regional Outlook

  • Geographically, the global medical cannabis market has been segmented into four major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World
  • The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • The report also profiles the following major players in the global medical cannabis market based on various attributes such as company overview, financial overview, product types, business strategies, and recent developments
    • Canopy Growth Corporation
    • United Cannabis
    • Aurora Cannabis
    • Cannabis Sativa, Inc.
    • Emerald Health Therapeutics
    • GW Pharmaceuticals plc
    • Tilray
    • Medical Marijuana, Inc.
    • The Supreme Cannabis Company, Inc.
    • The Cronos Group

Medical Cannabis Market – Segmentation

The report analyzes the global medical cannabis market based on derivative, application, route of administration, distribution channel, and region. Key segments under each criteria have been studied at length and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global medical cannabis market.

Derivative

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others

Application

  • Mental Health Management
    • Anxiety
    • Depression
    • Others
  • Neurological Disorders Management
    • Epilepsy
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Others
  • Pain Management
    • Neuropathic Pain
    • Cancer Pain
    • Others

Route of Administration

  • Nasal
  • Oral
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Latin America
  • Rest of the World

Frequently Asked Questions

The global medical cannabis market was worth US$ 8 Bn and is projected to reach a value of US$ 52.8 Bn by the end of 2027

Medical cannabis market is anticipated to grow at a CAGR of 27% during the forecast period

North America accounted for a major share of the global medical cannabis market

Medical cannabis market driven by projected growth in the number of countries that are expected to decriminalize cannabis for medical purposes and rise in the number of research activities pertaining to the potential benefits of medical cannabis are some of the leading factors that are expected to drive the market

Key players in the global medical cannabis market include Canopy Growth Corporation, United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, GW Pharmaceuticals plc, Tilray, Medical Marijuana, Inc., The Supreme Cannabis Company, Inc., and The Cronos Group

1. Preface 

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Medical Cannabis Market: Market Snapshot

4. Market Overview

    4.1. Global Medical Cannabis Market: Type Overview 

    4.2. Global Medical Cannabis Market: Key Industry Developments

    4.3. Market Dynamics

    4.4. Drivers and Restraints Snapshot Analysis

    4.5. Drivers

    4.6. Restraints

    4.7. Opportunities

    4.8. Global Medical Cannabis Market Revenue Projections (US$ Mn), 2017–2027

5. Key Insights

    5.1. Key Mergers & Acquisitions 

    5.2. Overview of Legal Medical Marijuana in the U.S. States

    5.3. Regulatory Scenario Assessment

    5.4. Review of Medical Cannabis Clinical Trials

    5.5. Top 3 players operating in the market

6. Global Medical Cannabis Market Analysis, by Derivative

    6.1. Introduction

    6.2. Global Medical Cannabis Market Value and Forecast, by Derivative

        6.2.1. Tetrahydrocannabinol (THC)

        6.2.2. Cannabidiol (CBD)

        6.2.3. Others

    6.3. Global Medical Cannabis Market Analysis, by Derivative

    6.4. Global Medical Cannabis Market Attractiveness Analysis, by Derivative

7. Global Medical Cannabis Market Analysis, by Application

    7.1. Introduction

    7.2. Global Medical Cannabis Market Value and Forecast, by Application

        7.2.1. Mental Health Management

            7.2.1.1. Anxiety

            7.2.1.2. Depression

            7.2.1.3. Others

        7.2.2. Neurological Disorders Management

            7.2.2.1. Epilepsy

            7.2.2.2. Alzheimer’s Disease

            7.2.2.3. Parkinson’s Disease

            7.2.2.4. Others 

        7.2.3. Pain Management

            7.2.3.1. Neuropathic Pain

            7.2.3.2. Cancer Pain

            7.2.3.3. Others

    7.3. Global Medical Cannabis Market Analysis, by Application

    7.4. Global Medical Cannabis Market Attractiveness Analysis, by Application

8. Global Medical Cannabis Market Analysis, by Route of Administration

    8.1. Introduction

    8.2. Global Medical Cannabis Market Value and Forecast, by Route of Administration

        8.2.1. Nasal

        8.2.2. Oral

        8.2.3. Others

    8.3. Global Medical Cannabis Market Analysis, by Route of Administration

    8.4. Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration

9. Global Medical Cannabis Market Analysis, by Distribution Channel

    9.1. Introduction

    9.2. Global Medical Cannabis Market Value and Forecast, by Distribution Channel

        9.2.1. Hospital Pharmacies

        9.2.2. Retail Pharmacies

        9.2.3. Online Pharmacies

    9.3. Global Medical Cannabis Market Analysis, by Distribution Channel

10. Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel

11. Global Medical Cannabis Market Analysis, by Region

    11.1. Global Medical Cannabis Market Value and Forecast, by Region, 2017–2027 

        11.1.1. North America

        11.1.2. Europe

        11.1.3. Latin America

        11.1.4. Rest of the World

    11.2. Global Medical Cannabis Market Analysis, by Region

    11.3. Global Medical Cannabis Market Attractiveness Analysis, by Region

12. North America Medical Cannabis Market Analysis

    12.1. North America Medical Cannabis Market 

    12.2. North America Medical Cannabis Market Overview

    12.3. North America Medical Cannabis Market Value and Forecast, by Derivative

        12.3.1. Tetrahydrocannabinol (THC)

        12.3.2. Cannabidiol (CBD)

        12.3.3. Others

    12.4. North America Medical Cannabis Market Value and Forecast, by Application

        12.4.1. Mental Health Management

            12.4.1.1. Anxiety

            12.4.1.2. Depression

            12.4.1.3. Others

        12.4.2. Neurological Disorders Management

            12.4.2.1. Epilepsy

            12.4.2.2. Alzheimer’s Disease

            12.4.2.3. Parkinson’s Disease

            12.4.2.4. Others 

        12.4.3. Pain Management

            12.4.3.1. Neuropathic Pain

            12.4.3.2. Cancer Pain

            12.4.3.3. Others

    12.5. North America Medical Cannabis Market Value and Forecast, by Route of Administration

        12.5.1. Nasal

        12.5.2. Oral

        12.5.3. Others

    12.6. North America Medical Cannabis Market Value and Forecast, by Distribution Channel

        12.6.1. Hospital Pharmacies

        12.6.2. Retail Pharmacies

        12.6.3. Online Pharmacies

    12.7. North America Medical Cannabis Market Forecast, by Country

        12.7.1. U.S.

        12.7.2. Canada

    12.8. North America Medical Cannabis Market Attractiveness Analysis 

        12.8.1. By Derivative

        12.8.2. By Application

        12.8.3. By Route of Administration

        12.8.4. By Distribution Channel

        12.8.5. By Country

13. Europe Medical Cannabis Market Analysis

    13.1. Europe Medical Cannabis Market 

    13.2. Europe Medical Cannabis Market Overview

    13.3. Europe Medical Cannabis Market Value and Forecast, by Derivative

        13.3.1. Tetrahydrocannabinol (THC)

        13.3.2. Cannabidiol (CBD)

        13.3.3. Others

    13.4. Europe Medical Cannabis Market Value and Forecast, by Application

        13.4.1. Mental Health Management

            13.4.1.1. Anxiety

            13.4.1.2. Depression

            13.4.1.3. Others

        13.4.2. Neurological Disorders Management

            13.4.2.1. Epilepsy

            13.4.2.2. Alzheimer’s Disease

            13.4.2.3. Parkinson’s Disease

            13.4.2.4. Others 

        13.4.3. Pain Management

            13.4.3.1. Neuropathic Pain

            13.4.3.2. Cancer Pain

            13.4.3.3. Others

    13.5. Europe Medical Cannabis Market Value and Forecast, by Route of Administration

        13.5.1. Nasal

        13.5.2. Oral

        13.5.3. Others

    13.6. Europe Medical Cannabis Market Value and Forecast, by Distribution Channel

        13.6.1. Hospital Pharmacies

        13.6.2. Retail Pharmacies

        13.6.3. Online Pharmacies

    13.7. Europe Medical Cannabis Market Forecast, by Country/Sub-region

        13.7.1. U.K.

        13.7.2. France

        13.7.3. Germany

        13.7.4. Spain

        13.7.5. Italy

        13.7.6. Rest of Europe

    13.8. Europe Medical Cannabis Market Attractiveness Analysis 

        13.8.1. By Derivative

        13.8.2. By Application

        13.8.3. By Route of Administration

        13.8.4. By Distribution Channel

        13.8.5. By Country/Sub-region

14. Latin America Medical Cannabis Market Analysis

    14.1. Latin America Medical Cannabis Market 

    14.2. Latin America Medical Cannabis Market Overview

    14.3. Latin America Medical Cannabis Market Value and Forecast, by Derivative

        14.3.1. Tetrahydrocannabinol (THC)

        14.3.2. Cannabidiol (CBD)

        14.3.3. Others

    14.4. Latin America Medical Cannabis Market Value and Forecast, by Application

        14.4.1. Mental Health Management

            14.4.1.1. Anxiety

            14.4.1.2. Depression

            14.4.1.3. Others

        14.4.2. Neurological Disorders Management

            14.4.2.1. Epilepsy

            14.4.2.2. Alzheimer’s Disease

            14.4.2.3. Parkinson’s Disease

            14.4.2.4. Others 

        14.4.3. Pain Management

            14.4.3.1. Neuropathic Pain

            14.4.3.2. Cancer Pain

            14.4.3.3. Others

    14.5. Latin America Medical Cannabis Market Value and Forecast, by Route of Administration

        14.5.1. Nasal

        14.5.2. Oral

        14.5.3. Others

    14.6. Latin America Medical Cannabis Market Value and Forecast, by Distribution Channel

        14.6.1. Hospital Pharmacies

        14.6.2. Retail Pharmacies

        14.6.3. Online Pharmacies

    14.7. Latin America Medical Cannabis Market Forecast, by Country/Sub-region

        14.7.1. Brazil

        14.7.2. Mexico

        14.7.3. Rest of Latin America

    14.8. Latin America Medical Cannabis Market Attractiveness Analysis 

        14.8.1. By Derivative

        14.8.2. By Application

        14.8.3. By Route of Administration

        14.8.4. By Distribution Channel

        14.8.5. By Country/Sub-region

15. Rest of the World Medical Cannabis Market Analysis

    15.1. Rest of the World Medical Cannabis Market 

    15.2. Rest of the World Medical Cannabis Market Overview

    15.3. Rest of the World Medical Cannabis Market Value and Forecast, by Derivative

        15.3.1. Tetrahydrocannabinol (THC)

        15.3.2. Cannabidiol (CBD)

        15.3.3. Others

    15.4. Rest of the World Medical Cannabis Market Value and Forecast, by Application

        15.4.1. Mental Health Management

            15.4.1.1. Anxiety

            15.4.1.2. Depression

            15.4.1.3. Others

        15.4.2. Neurological Disorders Management

            15.4.2.1. Epilepsy

            15.4.2.2. Alzheimer’s Disease

            15.4.2.3. Parkinson’s Disease

            15.4.2.4. Others 

        15.4.3. Pain Management

            15.4.3.1. Neuropathic Pain

            15.4.3.2. Cancer Pain

            15.4.3.3. Others

    15.5. Rest of the World Medical Cannabis Market Value and Forecast, by Route of Administration

        15.5.1. Nasal

        15.5.2. Oral

        15.5.3. Others

    15.6. Rest of the World Medical Cannabis Market Value and Forecast, by Distribution Channel

        15.6.1. Hospital Pharmacies

        15.6.2. Retail Pharmacies

        15.6.3. Online Pharmacies

    15.7. Rest of the World Medical Cannabis Market Attractiveness Analysis 

        15.7.1. By Derivative

        15.7.2. By Application

        15.7.3. By Route of Administration

        15.7.4. By Distribution Channel

16. Competitive Landscape 

    16.1. Company Profiles

        16.1.1. Canopy Growth Corporation

            16.1.1.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.1.2. Financials

            16.1.1.3. Recent Developments

            16.1.1.4. Strategy

        16.1.2. United Cannabis 

            16.1.2.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.2.2. Financials

            16.1.2.3. Recent Developments

            16.1.2.4. Strategy

        16.1.3. Aurora Cannabis

            16.1.3.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.3.2. Financials

            16.1.3.3. Recent Developments

            16.1.3.4. Strategy

        16.1.4. Cannabis Sativa, Inc.

            16.1.4.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.4.2. Financials

            16.1.4.3. Recent Developments

            16.1.4.4. Strategy

        16.1.5. Emerald Health Therapeutics

            16.1.5.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.5.2. Financials

            16.1.5.3. Recent Developments

            16.1.5.4. Strategy

        16.1.6. GW Pharmaceuticals plc. 

            16.1.6.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.6.2. Recent Developments

            16.1.6.3. Strategy

        16.1.7. Tilray

            16.1.7.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.7.2. Recent Developments

            16.1.7.3. Strategy

        16.1.8. Medical Marijuana, Inc. 

            16.1.8.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.8.2. Financials

            16.1.8.3. Recent Developments

            16.1.8.4. Strategy

        16.1.9. The Cronos Group. 

            16.1.9.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.9.2. Financials

            16.1.9.3. Recent Developments

            16.1.9.4. Strategy

        16.1.10. The Supreme Cannabis Company, Inc.

            16.1.10.1. Overview (HQ, Employee Strength, Business Segments)

            16.1.10.2. Recent Developments

            16.1.10.3. Strategy

List of Tables

TABLE 1 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 2 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 3 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 4 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 5 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 6 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 7 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

TABLE 8 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Region, 2017–2027

TABLE 9 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Country, 2017–2027 

TABLE 10 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027 

TABLE 11 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 12 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 13 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 14 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 15 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027 

TABLE 16 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027 

TABLE 17 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

TABLE 18 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027 

TABLE 19 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 20 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 21 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 22 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 23 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027 

TABLE 24 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027 

TABLE 25 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

TABLE 26 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027 

TABLE 27 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 28 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 29 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 30 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 31 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027 

TABLE 32 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027 

TABLE 33 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027 

TABLE 34 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 35 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 36 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 37 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 38 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027 

TABLE 39 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figures

Figure 1: Global Medical Cannabis Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 2: Global Medical Cannabis Market Value (US$ Mn), by Derivative, 2018

Figure 3: Global Medical Cannabis Market Value Share Analysis by Derivative, 2018

Figure 4: Market Overview

Figure 5: Global Medical Cannabis Market Value (US$ Mn) Forecast, 2017–2027

Figure 6: Global Medical Cannabis Market Value Share, by Derivative, 2018

Figure 7: Global Medical Cannabis Market Value Share, by Application, 2018

Figure 8: Global Medical Cannabis Market Value Share, by Distribution Channel, 2018

Figure 9: Global Medical Cannabis Market Value Share, by Region, 2018

Figure 10: Global Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027

Figure 11: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Tetrahydrocannabinol (THC), 2017–2027

Figure 12: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Cannabidiol (CBD), 2017–2027

Figure 13: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 14: Global Medical Cannabis Market Attractiveness Analysis, by Derivative 2019-2027

Figure 15: Global Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027

Figure 16: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth, by Mental Health Management, 2017–2027

Figure 17: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth, by Neurological Disorders Management, 2017–2027

Figure 18: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Pain Management, 2017–2027

Figure 19: Global Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027

Figure 20: Global Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 21: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Nasal, 2017–2027

Figure 22: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027

Figure 23: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 24: Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 25: Global Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 26: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 27: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 28: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2027

Figure 29: Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 30: Global Medical Cannabis Market Value Share Analysis, by Region, 2018 and 2027

Figure 31: Global Medical Cannabis Market Attractiveness Analysis, by Region, 2019–2027

Figure 32: North America Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 33: North America Medical Cannabis Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: North America Medical Cannabis Market Attractiveness Analysis, by Country, 2019–2027

Figure 35: North America Medical Cannabis Market Value Share, by Derivative, 2018 and 2027

Figure 36: North America Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027

Figure 37: North America Medical Cannabis Market Value Share, by Application, 2018 and 2027

Figure 38: North America Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027

Figure 39: North America Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027 

Figure 40: North America Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027 

Figure 41: North America Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027 

Figure 42: North America Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027 

Figure 43: Europe Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 44: Europe Medical Cannabis Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 45: Europe Medical Cannabis Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 46: Europe Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027

Figure 47: Europe Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027

Figure 48: Europe Medical Cannabis Market Value Share, by Application, 2018 and 2027

Figure 49: Europe Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027

Figure 50: Europe Medical Cannabis Market Value Share, by Route of Administration, 2018 and 2027 

Figure 51: Europe Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027 

Figure 52: Europe Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027 

Figure 53: Europe Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027 

Figure 54: Latin America Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 55: Latin America Medical Cannabis Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56: Latin America Medical Cannabis Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 57: Latin America Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027

Figure 58: Latin America Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027

Figure 59: Latin America Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027

Figure 60: Latin America Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027

Figure 61: Latin America Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027 

Figure 62: Latin America Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027 

Figure 63: Latin America Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027 

Figure 64: Latin America Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027 

Figure 65: Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 66: Rest of the World Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027

Figure 67: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027

Figure 68: Rest of the World Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027

Figure 69: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027

Figure 70: Rest of the World Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027 

Figure 71: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027 

Figure 72: Rest of the World Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027 

Figure 73: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027 

Figure 74: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Medical Cannabis Market